Inclusion Criteria:  age 18-39 years at the time of participation diagnosed with a non-metastatic primary cancer between 18-39 years old completed primary cancer treatment (excepting hormone therapy) 1 month to 5 years prior to enrollment able to speak and read English access to internet or cellular connectivity with sufficient bandwidth to participate in videoconferences  Exclusion Criteria:  metastatic disease psychiatric or neurological disorders that could interfere with study participation considered part of a vulnerable population